Professor Claudia Langenberg, MSc Dr med PhD FFPH

Profile

Claudia leads teams in London (PHURI) and Berlin (BIH) and is consultant of public health at the Department of Health and Social Care and Barts Health NHS Trust, London. Her research is focused on the genetic regulation of human metabolism and her work has transformed the use and integration of large-scale, high-resolution molecular and clinical data to systematically characterize genetic effects across organs, tissues and cells and advance our understanding of the causes of diverse human diseases (www.omicscience.org). 

Claudia is a member of the European Molecular Biology Organization (EMBO) and has been named in the Best Female Scientists in the World Ranking since 2022. 

Research

Publications

• Barente A, Zhao Z, Zheng Z et al. (publicationYear). Systematic comparison of affinity plasma proteomic technologies across multiple cohorts reveals generalizability of proteomic prediction. nameOfConference

  
  

  DOI: 10.1038/s41467-026-78443-7

  
  

  QMRO: qmroHref
• Xie T, Luo S, Thio CHL et al. (2026). Effects of Polygenic Risk Scores and Physical Activity on Blood Pressure Trajectories in Childhood, Adolescence, and Young Adulthood. nameOfConference

  
  

  DOI: 10.1161/circgen.125.004307

  
  

  QMRO: qmroHref
• Carrasco-Zanini J, Andrade J, Pietzner M et al. (2026). Proteomics identify disease-associated variants in patients with rare diseases undiagnosed after genome sequencing. nameOfConference

  
  

  DOI: 10.1126/scitranslmed.aeb1331

  
  

  QMRO: https://qmro.qmul.ac.uk/handle/123456789/131839
• Manchanda Y, Desoki R, Gardner EJ et al. (2026). Glycemic and bodyweight effects of GIPR coding variation reflect differences in surface expression and intrinsic functional impairment. nameOfConference

  
  

  DOI: 10.1126/sciadv.aec3372

  
  

  QMRO: qmroHref
• Pietzner M, Williamson A, Hunt KA et al. (2026). Nanoparticle-enriched mass spectrometry proteomics in British South Asians identifies links between genetic variants, plasma protein levels and disease risk. nameOfConference

  
  

  DOI: 10.1038/s41588-026-02697-6

  
  

  QMRO: qmroHref
• Uluvar B, Williamson A, Kolnes KJ et al. (2026). Tissue origins of the plasma proteomic response to glucose ingestion in humans. nameOfConference

  
  

  DOI: 10.1007/s00125-026-06800-8

  
  

  QMRO: qmroHref
• Ferolito BR, Horimoto ARVR, Gravel-Pucillo K et al. (publicationYear). A genomic-led strategy to anticipate drug safety effects. nameOfConference

  
  

  DOI: 10.1371/journal.pgen.1012211

  
  

  QMRO: qmroHref
• Robinson O, Xiao H, Homann J et al. (2026). Associations of proteomic age clocks with lifestyle risk factors, incident chronic diseases and mortality in two European cohorts. nameOfConference

  
  

  DOI: 10.1038/s43587-026-01163-6

  
  

  QMRO: qmroHref
• Dayem Ullah AZM, Joby A, Thorn GJ et al. (publicationYear). Genetic and health determinants of cancer risk in Bangladeshi and Pakistani individuals in the UK. nameOfConference

  
  

  DOI: 10.1038/s41467-026-74415-z

  
  

  QMRO: qmroHref
• Franks PW, Suliman SGI, Timpson NJ et al. (2026). Data-Driven Decision Support in Obesity Management Commission: enabling more equitable and personalized obesity care. nameOfConference

  
  

  DOI: 10.1038/s41591-026-04363-0

  
  

  QMRO: qmroHref